Delivery Order SPE2DB20D2014-SPE2DB25FC85J
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,072.32 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, a continuous glucose monitoring device used for diabetes management. The contract is a firm fixed price delivery order with a completion date of September 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this order. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,720.12 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of June 9, 2025. This non-compete, firm fixed-price delivery order was issued on June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor supporting federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,626.60 to supply Freestyle Libre 3 Plus Sensors, continuous glucose monitoring devices for diabetes management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 7, 2025. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $18,029.34 delivery order to AmerisourceBergen Drug Corp for FreeStyle Libre 3 Plus sensors, a continuous glucose monitoring system used for diabetes management. This firm fixed-price contract, awarded on September 3, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.99 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 25, 2025. This non-competitive, firm fixed-price delivery order represents a procurement of continuous glucose monitoring sensors to support military and federal healthcare supply chains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a $5,575.44 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus continuous glucose monitoring sensors, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $38,788.88 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,441.98 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a routine medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $10,768.98 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Sensors, with an ultimate completion date of August 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC85JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,393.79 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order with a completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical supply distributor for federal healthcare programs, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical devices to support military healthcare programs worldwide. The award of this specific delivery order for diabetes management technology demonstrates the company's role in providing specialized medical commodities across multiple therapeutic domains to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/27/25 |